B. Rawson, N. S. “Regulatory Approval and Public Drug Plan Listing of New Drugs for Rare Disorders in Canada and New Zealand”. Journal of Population Therapeutics and Clinical Pharmacology, vol. 27, no. 2, June 2020, pp. e58-e67, doi:10.15586/jptcp.v27i2.673.